R1 RCM Inc. (NASDAQ:RCM) Receives $15.41 Consensus Price Target from Analysts

R1 RCM Inc. (NASDAQ:RCM) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are covering the company, Marketbeat reports. Thirteen investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $15.41.

RCM has been the topic of a number of research reports. Leerink Partnrs lowered R1 RCM from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. Truist Financial reduced their price target on shares of R1 RCM from $16.00 to $14.30 and set a “hold” rating for the company in a research report on Thursday, August 8th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $14.30 price objective on shares of R1 RCM in a report on Friday, October 4th. Jefferies Financial Group cut shares of R1 RCM from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Finally, TD Cowen reaffirmed a “hold” rating and issued a $14.30 price target (down from $20.00) on shares of R1 RCM in a report on Monday, August 5th.

Institutional Trading of R1 RCM

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Glazer Capital LLC acquired a new stake in shares of R1 RCM in the third quarter valued at about $135,678,000. Boston Partners lifted its stake in R1 RCM by 4,976.6% in the 1st quarter. Boston Partners now owns 2,570,371 shares of the healthcare provider’s stock worth $32,784,000 after purchasing an additional 2,519,739 shares in the last quarter. Empyrean Capital Partners LP acquired a new position in shares of R1 RCM during the 2nd quarter worth approximately $26,376,000. Alpine Associates Management Inc. acquired a new stake in shares of R1 RCM in the third quarter valued at approximately $25,680,000. Finally, First Light Asset Management LLC grew its holdings in R1 RCM by 212.8% in the 1st quarter. First Light Asset Management LLC now owns 2,552,325 shares of the healthcare provider’s stock valued at $32,874,000 after buying an additional 1,736,346 shares in the last quarter. Hedge funds and other institutional investors own 61.10% of the company’s stock.

R1 RCM Price Performance

NASDAQ:RCM opened at $14.31 on Thursday. The company has a current ratio of 1.79, a quick ratio of 1.79 and a debt-to-equity ratio of 0.76. R1 RCM has a twelve month low of $8.87 and a twelve month high of $15.12. The company has a market cap of $6.04 billion, a PE ratio of -95.39 and a beta of 0.84. The company’s 50 day moving average is $14.23 and its two-hundred day moving average is $13.48.

R1 RCM (NASDAQ:RCM) last posted its quarterly earnings data on Tuesday, November 5th. The healthcare provider reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.04). R1 RCM had a negative return on equity of 2.18% and a negative net margin of 2.48%. The company had revenue of $656.80 million for the quarter, compared to analyst estimates of $640.93 million. The company’s quarterly revenue was up 14.7% compared to the same quarter last year. Analysts anticipate that R1 RCM will post -0.18 EPS for the current year.

About R1 RCM

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.